$CLVS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Clovis Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Clovis Oncology, Inc.. Get notifications about new insider transactions in Clovis Oncology, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 563 | 0 | 23,043 | 22.5 K to 23 K (+2.50 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 7.20 | 216 | 1,555 | 22,480 | 22.7 K to 22.5 K (-0.95 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 469 | 0 | 22,696 | 22.2 K to 22.7 K (+2.11 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 688 | 0 | 5,500 | |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 2,500 | |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 7.20 | 317 | 2,282 | 203,775 | 204.1 K to 203.8 K (-0.16 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 688 | 0 | 204,092 | 203.4 K to 204.1 K (+0.34 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 7.20 | 288 | 2,074 | 203,404 | 203.7 K to 203.4 K (-0.14 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 203,692 | 203.1 K to 203.7 K (+0.31 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 688 | 0 | 5,500 | |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 2,500 | |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 7.20 | 360 | 2,592 | 34,348 | 34.7 K to 34.3 K (-1.04 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 688 | 0 | 34,708 | 34 K to 34.7 K (+2.02 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 7.20 | 327 | 2,354 | 34,020 | 34.3 K to 34 K (-0.95 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 625 | 0 | 34,347 | 33.7 K to 34.3 K (+1.85 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Option Exercise | M | 0.00 | 563 | 0 | 4,500 | |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Option Exercise | M | 0.00 | 469 | 0 | 1,875 | |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Sell | S | 7.20 | 259 | 1,865 | 19,345 | 19.6 K to 19.3 K (-1.32 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Buy | M | 0.00 | 563 | 0 | 19,604 | 19 K to 19.6 K (+2.96 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Sell | S | 7.20 | 216 | 1,555 | 19,041 | 19.3 K to 19 K (-1.12 %) |
| Mar 05 2020 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Buy | M | 0.00 | 469 | 0 | 19,257 | 18.8 K to 19.3 K (+2.50 %) |
| Mar 02 2020 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 547 | 0 | 1,094 | |
| Mar 02 2020 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 6.90 | 279 | 1,925 | 22,227 | 22.5 K to 22.2 K (-1.24 %) |
| Mar 02 2020 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 547 | 0 | 22,506 | 22 K to 22.5 K (+2.49 %) |
| Feb 18 2020 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Option Exercise | A | 9.71 | 50,000 | 485,500 | 50,000 | |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 22,497 | 0 | 67,485 | |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 8.41 | 5,429 | 45,658 | 21,959 | 27.4 K to 22 K (-19.82 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 12,271 | 0 | 27,388 | 15.1 K to 27.4 K (+81.17 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 8.41 | 5,043 | 42,412 | 15,117 | 20.2 K to 15.1 K (-25.01 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 10,226 | 0 | 20,160 | 9.9 K to 20.2 K (+102.94 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 14,997 | 0 | 44,991 | |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 8.41 | 7,204 | 60,586 | 203,067 | 210.3 K to 203.1 K (-3.43 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 14,997 | 0 | 210,271 | 195.3 K to 210.3 K (+7.68 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Option Exercise | M | 0.00 | 22,497 | 0 | 67,485 | |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Sell | S | 8.41 | 5,427 | 45,641 | 18,788 | 24.2 K to 18.8 K (-22.41 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Buy | M | 0.00 | 12,271 | 0 | 24,215 | 11.9 K to 24.2 K (+102.74 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Sell | S | 8.41 | 5,043 | 42,412 | 11,944 | 17 K to 11.9 K (-29.69 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Buy | M | 0.00 | 10,226 | 0 | 16,987 | 6.8 K to 17 K (+151.25 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 14,997 | 0 | 44,991 | |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 8.41 | 7,503 | 63,100 | 33,722 | 41.2 K to 33.7 K (-18.20 %) |
| Feb 06 2020 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 14,997 | 0 | 41,225 | 26.2 K to 41.2 K (+57.18 %) |
| Feb 03 2020 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Option Exercise | A | 8.39 | 50,000 | 419,500 | 50,000 | |
| Feb 03 2020 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Option Exercise | A | 8.39 | 200,000 | 1,678,000 | 200,000 | |
| Jan 31 2020 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | A | 0.00 | 74,000 | 0 | 74,000 | |
| Jan 31 2020 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Option Exercise | A | 0.00 | 74,000 | 0 | 74,000 | |
| Jan 31 2020 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | A | 0.00 | 74,000 | 0 | 74,000 | |
| Jan 31 2020 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 0.00 | 74,000 | 0 | 74,000 | |
| Dec 26 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 3,438 | 0 | 13,750 | |
| Dec 26 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 11.30 | 1,729 | 19,538 | 26,228 | 28 K to 26.2 K (-6.18 %) |
| Dec 26 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 3,438 | 0 | 27,957 | 24.5 K to 28 K (+14.02 %) |
| Dec 26 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 7,500 | |
| Dec 26 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 11.30 | 830 | 9,379 | 195,274 | 196.1 K to 195.3 K (-0.42 %) |
| Dec 26 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 196,104 | 194.2 K to 196.1 K (+0.97 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 687 | 0 | 6,188 | |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 3,125 | |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 14.61 | 353 | 5,157 | 24,519 | 24.9 K to 24.5 K (-1.42 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 687 | 0 | 24,872 | 24.2 K to 24.9 K (+2.84 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 14.59 | 321 | 4,683 | 24,185 | 24.5 K to 24.2 K (-1.31 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 625 | 0 | 24,506 | 23.9 K to 24.5 K (+2.62 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 562 | 0 | 5,063 | |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 469 | 0 | 2,344 | |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 14.59 | 254 | 3,706 | 9,934 | 10.2 K to 9.9 K (-2.49 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 562 | 0 | 10,188 | 9.6 K to 10.2 K (+5.84 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 14.59 | 212 | 3,093 | 9,626 | 9.8 K to 9.6 K (-2.15 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 469 | 0 | 9,838 | 9.4 K to 9.8 K (+5.01 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Option Exercise | M | 0.00 | 562 | 0 | 5,063 | |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Option Exercise | M | 0.00 | 469 | 0 | 2,344 | |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Sell | S | 14.59 | 254 | 3,706 | 6,500 | 6.8 K to 6.5 K (-3.76 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Buy | M | 0.00 | 562 | 0 | 6,754 | 6.2 K to 6.8 K (+9.08 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Sell | S | 14.59 | 212 | 3,093 | 6,192 | 6.4 K to 6.2 K (-3.31 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Buy | M | 0.00 | 469 | 0 | 6,404 | 5.9 K to 6.4 K (+7.90 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 687 | 0 | 6,188 | |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 3,125 | |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 14.59 | 310 | 4,523 | 194,229 | 194.5 K to 194.2 K (-0.16 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 687 | 0 | 194,539 | 193.9 K to 194.5 K (+0.35 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 14.60 | 282 | 4,117 | 193,852 | 194.1 K to 193.9 K (-0.15 %) |
| Dec 05 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 194,134 | 193.5 K to 194.1 K (+0.32 %) |
| Nov 29 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 546 | 0 | 1,641 | |
| Nov 29 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 10.20 | 242 | 2,468 | 9,369 | 9.6 K to 9.4 K (-2.52 %) |
| Nov 29 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 546 | 0 | 9,611 | 9.1 K to 9.6 K (+6.02 %) |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 9,375 | |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 9,375 | |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 4.80 | 837 | 4,018 | 193,509 | 194.3 K to 193.5 K (-0.43 %) |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 4.80 | 837 | 4,018 | 193,509 | 194.3 K to 193.5 K (-0.43 %) |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 194,346 | 192.5 K to 194.3 K (+0.97 %) |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 194,346 | 192.5 K to 194.3 K (+0.97 %) |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 3,437 | 0 | 17,188 | |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 3,437 | 0 | 17,188 | |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 4.80 | 1,744 | 8,371 | 23,881 | 25.6 K to 23.9 K (-6.81 %) |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 4.80 | 1,744 | 8,371 | 23,881 | 25.6 K to 23.9 K (-6.81 %) |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 3,437 | 0 | 25,625 | 22.2 K to 25.6 K (+15.49 %) |
| Sep 24 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 3,437 | 0 | 25,625 | 22.2 K to 25.6 K (+15.49 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 688 | 0 | 6,875 | |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 3,750 | |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.21 | 330 | 1,719 | 192,471 | 192.8 K to 192.5 K (-0.17 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 688 | 0 | 192,801 | 192.1 K to 192.8 K (+0.36 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 5.21 | 300 | 1,563 | 192,113 | 192.4 K to 192.1 K (-0.16 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 192,413 | 191.8 K to 192.4 K (+0.33 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Option Exercise | M | 0.00 | 563 | 0 | 5,625 | |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Option Exercise | M | 0.00 | 469 | 0 | 2,813 | |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Sell | S | 5.21 | 270 | 1,407 | 5,935 | 6.2 K to 5.9 K (-4.35 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Buy | M | 0.00 | 563 | 0 | 6,205 | 5.6 K to 6.2 K (+9.98 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Sell | S | 5.21 | 225 | 1,172 | 5,642 | 5.9 K to 5.6 K (-3.84 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Buy | M | 0.00 | 469 | 0 | 5,867 | 5.4 K to 5.9 K (+8.69 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 563 | 0 | 5,625 | |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 469 | 0 | 2,813 | |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 5.21 | 270 | 1,407 | 9,065 | 9.3 K to 9.1 K (-2.89 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 563 | 0 | 9,335 | 8.8 K to 9.3 K (+6.42 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 5.21 | 225 | 1,172 | 8,772 | 9 K to 8.8 K (-2.50 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 469 | 0 | 8,997 | 8.5 K to 9 K (+5.50 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 688 | 0 | 6,875 | |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 3,750 | |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 5.21 | 375 | 1,954 | 22,188 | 22.6 K to 22.2 K (-1.66 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 688 | 0 | 22,563 | 21.9 K to 22.6 K (+3.15 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 5.21 | 341 | 1,777 | 21,875 | 22.2 K to 21.9 K (-1.53 %) |
| Sep 06 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 625 | 0 | 22,216 | 21.6 K to 22.2 K (+2.89 %) |
| Aug 28 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 547 | 0 | 2,187 | |
| Aug 28 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 6.09 | 239 | 1,456 | 8,528 | 8.8 K to 8.5 K (-2.73 %) |
| Aug 28 2019 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 547 | 0 | 8,767 | 8.2 K to 8.8 K (+6.65 %) |
| Aug 22 2019 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | M | 0.29 | 25,862 | 7,500 | 0 | |
| Aug 22 2019 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Buy | M | 0.29 | 25,862 | 7,500 | 25,862 | 0 to 25.9 K |
| Aug 20 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 5.97 | 20,000 | 119,400 | 20,000 | 0 to 20 K |
| Aug 20 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 5.70 | 20,000 | 114,000 | 33,439 | 13.4 K to 33.4 K (+148.82 %) |
| Aug 20 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 5.97 | 20,000 | 119,400 | 20,000 | 0 to 20 K |
| Aug 20 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 5.70 | 20,000 | 114,000 | 33,439 | 13.4 K to 33.4 K (+148.82 %) |
| Aug 19 2019 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Buy | P | 5.60 | 5,827 | 32,631 | 968,787 | 963 K to 968.8 K (+0.61 %) |
| Aug 19 2019 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Buy | P | 5.60 | 5,100 | 28,560 | 962,960 | 957.9 K to 963 K (+0.53 %) |
| Aug 19 2019 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Buy | P | 5.59 | 11,053 | 61,786 | 957,860 | 946.8 K to 957.9 K (+1.17 %) |
| Aug 19 2019 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Buy | P | 5.59 | 3,700 | 20,683 | 946,807 | 943.1 K to 946.8 K (+0.39 %) |
| Aug 19 2019 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Buy | P | 5.58 | 11,314 | 63,132 | 943,107 | 931.8 K to 943.1 K (+1.21 %) |
| Aug 19 2019 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Buy | P | 5.61 | 6,400 | 35,904 | 931,793 | 925.4 K to 931.8 K (+0.69 %) |
| Aug 19 2019 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Buy | P | 5.61 | 2,100 | 11,781 | 925,393 | 923.3 K to 925.4 K (+0.23 %) |
| Aug 19 2019 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Buy | P | 5.57 | 3,706 | 20,642 | 923,293 | 919.6 K to 923.3 K (+0.40 %) |
| Aug 19 2019 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Buy | P | 5.58 | 400 | 2,232 | 919,587 | 919.2 K to 919.6 K (+0.04 %) |
| Aug 19 2019 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | President and CEO | Buy | P | 5.56 | 400 | 2,224 | 919,187 | 918.8 K to 919.2 K (+0.04 %) |
| Aug 16 2019 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Buy | P | 5.67 | 8,600 | 48,762 | 58,176 | 49.6 K to 58.2 K (+17.35 %) |
| Aug 15 2019 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Buy | P | 5.46 | 9,200 | 50,232 | 49,576 | 40.4 K to 49.6 K (+22.79 %) |
| Aug 15 2019 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Buy | P | 5.46 | 9,200 | 50,232 | 49,576 | 40.4 K to 49.6 K (+22.79 %) |
| Jul 31 2019 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | M | 0.29 | 25,862 | 7,500 | 0 | |
| Jul 31 2019 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Buy | M | 0.29 | 25,862 | 7,500 | 59,327 | 33.5 K to 59.3 K (+77.28 %) |
| Jun 24 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 3,438 | 0 | 20,625 | |
| Jun 24 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 14.70 | 1,728 | 25,402 | 21,591 | 23.3 K to 21.6 K (-7.41 %) |
| Jun 24 2019 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 3,438 | 0 | 23,319 | 19.9 K to 23.3 K (+17.29 %) |
| Jun 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 11,250 | |
| Jun 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 14.70 | 829 | 12,186 | 191,788 | 192.6 K to 191.8 K (-0.43 %) |
| Jun 24 2019 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 192,617 | 190.7 K to 192.6 K (+0.98 %) |
| Jun 10 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 | |
| Jun 07 2019 | CLVS | Clovis Oncology, I ... | McKinley Edward J | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 | |
| Jun 07 2019 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 | |
| Jun 07 2019 | CLVS | Clovis Oncology, I ... | Azelby Robert | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 |